Laboratorios Farmaceuticos Rovi, S.A. (LON: 0ILL)

Laboratorios Farmaceuticos Rovi Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 22, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	2,677	2,788	1,707	3,475	1,881	1,145
Market Cap Growth	28.21%	63.31%	-50.88%	84.77%	64.27%	31.90%
Enterprise Value	2,777	2,797	1,687	3,415	1,916	1,147
Last Close Price	52.26	52.24	31.30	59.03	32.68	19.52
PE Ratio	-	18.80	9.45	25.47	33.09	32.36
PS Ratio	4.58	3.87	2.35	6.38	5.00	3.54
PB Ratio	6.56	5.91	3.69	8.79	5.62	4.19
P/TBV Ratio	7.10	6.28	3.92	9.42	6.18	4.74
P/FCF Ratio	55.61	54.04	10.30	37.88	278.47	-
P/OCF Ratio	29.02	28.37	8.10	27.69	44.79	-
EV/Sales Ratio	4.18	3.89	2.33	6.27	5.09	3.55
EV/EBITDA Ratio	14.01	13.54	7.01	20.68	23.87	24.41
EV/EBIT Ratio	15.73	14.69	7.50	22.57	28.55	32.19
EV/FCF Ratio	50.67	54.22	10.18	37.22	283.73	-
Debt / Equity Ratio	0.23	0.12	0.14	0.16	0.20	0.26
Debt / EBITDA Ratio	0.54	0.27	0.26	0.36	0.80	1.44
Debt / FCF Ratio	1.95	1.10	0.39	0.67	9.87	-
Asset Turnover	0.94	0.99	1.01	0.99	0.77	0.83
Inventory Turnover	0.87	1.07	1.10	1.14	0.95	1.34
Quick Ratio	0.92	0.83	1.04	1.35	1.10	1.48
Current Ratio	2.50	2.55	2.12	2.66	2.97	2.98
Return on Equity (ROE)	29.65%	31.98%	40.24%	36.25%	17.54%	12.88%
Return on Assets (ROA)	15.55%	16.34%	19.68%	17.23%	8.63%	5.75%
Return on Capital (ROIC)	20.36%	22.81%	27.88%	22.69%	10.95%	7.21%
Earnings Yield	4.92%	5.30%	10.37%	3.70%	2.91%	2.91%
FCF Yield	1.80%	1.85%	9.71%	2.64%	0.36%	-2.59%
Dividend Yield	1.20%	1.83%	3.67%	1.36%	1.05%	0.76%
Payout Ratio	34.21%	40.54%	25.55%	13.80%	15.89%	11.25%
Buyback Yield / Dilution	0.51%	3.50%	-0.03%	-0.37%	-7.73%
Total Shareholder Return	2.35%	7.16%	1.33%	0.67%	-6.96%

Source: S&P Capital IQ. Standard template. Financial Sources.